股票 › DMRA
Damora 制药 DMRA
美股市值排名 #2960
$23.70 +$1.84 (+8.42%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $23.70 0.00%
开盘$22.01
昨收$21.86
当日区间$21.13 – $24.25
成交量360.5K
市值$1.47B
市盈率（TTM）13.9
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$34.99M-922.9% YoY
净利润-$31.17M-807.0% YoY
摊薄每股收益-$0.39+85.0% YoY
自由现金流-$21.87M-877.5% YoY
经营现金流-$21.87M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-132.8%
资产收益率-94.3%
投入资本回报率-135.3%
流动比率19.73
负债/资产比率5.1%
现金及投资$540.52M
净现金（净负债）$540.52M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $34.99M | $30.81M | $210.87M | $201.70M | $3.16M |
| 销售及管理费用 | $9.45M | $7.03M | $9.69M | $4.07M | $1.74M |
| -管理费用 | $9.45M | $7.03M | $9.69M | $4.07M | $1.74M |
| 研发费用 | $25.54M | $23.78M | $201.19M | $197.63M | $1.42M |
| 营业利润 | -$34.99M | -$30.81M | -$210.87M | -$201.70M | -$3.16M |
| 非经营性利息净收入（支出） | $4.06M | $3.07M | $1.17M | $1.00M | $42,000.00 |
| 非经营性利息收入 | $4.06M | $3.07M | $1.17M | $1.00M | $42,000.00 |
| 其他收入（支出） | $16,000.00 | – | -$84,000.00 | $3,000.00 | -$19,000.00 |
| 证券出售收益 | $16,000.00 | – | -$84,000.00 | $3,000.00 | -$19,000.00 |
| 税前利润 | -$30.92M | -$27.74M | -$209.79M | -$200.69M | -$3.13M |
| 税费 | $255,000.00 | $42,000.00 | $50,000.00 | $44,000.00 | $0.00 |
| 净利润 | -$31.17M | -$27.78M | -$209.84M | -$200.74M | -$3.13M |
| 持续经营利润 | -$31.17M | -$27.78M | -$209.84M | -$200.74M | -$3.13M |
| 归属母公司净利润 | -$31.17M | -$27.78M | -$209.84M | -$200.74M | -$3.13M |
| 归属普通股股东净利润 | -$31.17M | -$27.78M | -$209.84M | -$200.74M | -$3.13M |
| 基本每股收益 | -$0.39 | -$0.62 | -$3.98 | $2.90 | -$2.36 |
| 摊薄每股收益 | -$0.39 | -$0.62 | -$3.98 | $2.90 | -$2.36 |
| 特殊收益（费用） | – | – | $0.00 | $0.00 | $0.00 |
| -减：重组及并购费用 | – | – | $0.00 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $543.64M | $535.44M | $260.53M | $260.53M | $10.74M |
| 流动资产合计 | $543.59M | $535.41M | $260.42M | $260.42M | $9.79M |
| 现金及现金等价物与短期投资 | $540.52M | $532.90M | $257.62M | $257.62M | $7.61M |
| -现金及现金等价物 | $540.52M | $532.90M | $257.62M | $257.62M | $7.61M |
| 应收款 | $880,000.00 | $894,000.00 | $899,000.00 | $899,000.00 | $992,000.00 |
| -应收税款 | $880,000.00 | $894,000.00 | $899,000.00 | $899,000.00 | $992,000.00 |
| 预付资产 | $243,000.00 | $410,000.00 | $577,000.00 | $577,000.00 | $56,000.00 |
| 一年内递延资产 | $655,000.00 | $1.21M | $1.20M | $1.20M | $1.02M |
| 其他流动资产 | $1.30M | – | $125,000.00 | $125,000.00 | $115,000.00 |
| 非流动资产合计 | $48,000.00 | $34,000.00 | $104,000.00 | $104,000.00 | $950,000.00 |
| 其他非流动资产 | $48,000.00 | $34,000.00 | – | – | $837,000.00 |
| 负债合计 | $27.58M | $23.84M | $20.15M | $20.15M | $2.73M |
| 流动负债合计 | $27.55M | $23.81M | $20.07M | $20.07M | $2.62M |
| 应付款 | $9.14M | $12.83M | $17.67M | $17.67M | $520,000.00 |
| -应付账款 | $3.48M | $819,000.00 | $444,000.00 | $444,000.00 | $520,000.00 |
| -其他应付款 | $5.66M | $12.01M | $17.22M | $17.22M | – |
| 一年内应计费用 | $6.47M | $3.71M | $864,000.00 | $864,000.00 | $487,000.00 |
| 其他流动负债 | $10.63M | $6.31M | $1.08M | $1.08M | $372,000.00 |
| 非流动负债合计 | $27,000.00 | $27,000.00 | $81,000.00 | $81,000.00 | $106,000.00 |
| 其他非流动负债 | $27,000.00 | $27,000.00 | $28,000.00 | $28,000.00 | $49,000.00 |
| 股东权益合计 | $516.06M | $511.60M | $240.38M | $240.38M | $8.01M |
| 股东权益 | $516.06M | $511.60M | $240.38M | $240.38M | $8.01M |
| 股本 | $130.00M | $132.45M | $416.25M | $416.25M | $1.34M |
| -普通股 | $1,000.00 | $1,000.00 | $0.00 | $0.00 | $0.00 |
| -优先股 | $130.00M | $132.45M | $416.25M | $416.25M | $1.34M |
| 资本公积 | $931.65M | $893.54M | $310.69M | $310.69M | $292.47M |
| 留存收益 | -$546.32M | -$515.15M | -$487.36M | -$487.36M | -$286.63M |
| 不影响留存收益的损益 | $732,000.00 | $754,000.00 | $802,000.00 | $802,000.00 | $823,000.00 |
| 固定资产净值 | – | – | $104,000.00 | $104,000.00 | $113,000.00 |
| -固定资产原值 | – | – | $176,000.00 | $176,000.00 | $180,000.00 |
| -累计折旧 | – | – | -$72,000.00 | -$72,000.00 | -$67,000.00 |
| 短期债务及融资租赁负债 | – | – | $15,000.00 | $15,000.00 | $15,000.00 |
| -一年内到期融资租赁负债 | – | – | $15,000.00 | $15,000.00 | $15,000.00 |
| 长期债务及融资租赁负债 | – | – | $53,000.00 | $53,000.00 | $57,000.00 |
| -长期融资租赁负债 | – | – | $53,000.00 | $53,000.00 | $57,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$21.87M | -$20.60M | -$6.73M | $566,000.00 | -$2.62M |
| 持续经营经营活动现金流净额 | -$21.87M | -$20.60M | -$6.73M | $566,000.00 | -$2.62M |
| 持续经营净利润 | -$31.17M | -$27.78M | -$209.84M | -$200.74M | -$3.13M |
| 折旧、折耗与摊销 | $11,000.00 | $68,000.00 | $34,000.00 | $7,000.00 | $10,000.00 |
| 营运资金变动 | $3.15M | $3.98M | $18.36M | $17.14M | $332,000.00 |
| -预付资产变动 | -$564,000.00 | $290,000.00 | -$138,000.00 | -$620,000.00 | $637,000.00 |
| -应付账款及应计费用变动 | -$790,000.00 | -$1.24M | $18.37M | $16.95M | -$6,000.00 |
| -其他流动资产变动 | -$23,000.00 | $0.00 | $166,000.00 | $837,000.00 | -$295,000.00 |
| -其他流动负债变动 | -$14,000.00 | -$54,000.00 | -$35,000.00 | -$26,000.00 | -$4,000.00 |
| -其他营运资金变动 | $4.54M | $4.98M | – | – | – |
| 筹资活动现金流 | $29.51M | $295.92M | $266.84M | – | – |
| 持续经营筹资活动现金流净额 | $29.51M | $295.92M | $266.84M | – | – |
| 普通股发行净额 | $50.72M | $295.50M | – | – | – |
| 股票期权行使所得 | $226,000.00 | $424,000.00 | $33,000.00 | – | – |
| 期末现金余额 | $540.52M | $532.90M | $257.62M | $257.62M | $7.61M |
| 现金净变动 | $7.64M | $275.32M | $242.74M | $250.04M | -$2.62M |
| 期初现金余额 | $532.90M | $257.62M | $14.18M | $7.61M | $10.21M |
| 汇率变动影响 | -$22,000.00 | -$48,000.00 | $705,000.00 | -$18,000.00 | $11,000.00 |
| 自由现金流 | -$21.87M | -$20.60M | -$6.73M | $566,000.00 | -$2.62M |
| 持续经营损益 | – | – | $9.36M | – | – |
| 其他非现金项目 | – | – | $174.36M | $174.31M | $11,000.00 |
| 投资活动现金流净额 | – | – | -$17.37M | -$17.37M | – |
| 持续经营投资活动现金流净额 | – | – | -$17.37M | -$17.37M | – |
| 业务购买及出售净额 | – | – | -$17.37M | – | – |
| 投资购置及出售净额 | – | – | $0.00 | $0.00 | – |
| 优先股发行净额 | – | – | $266.81M | – | – |
暂无评论——快来第一个聊聊 DMRA。
登录后参与讨论。